Literature DB >> 3275499

Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines.

T C Shea1, S L Kelley, W D Henner.   

Abstract

Glutathione transferase (GST) activity and GST isoenzyme composition have been determined for 24 human neoplasms and 6 human tumor cell lines. Substantial activity (40-1010 milliunits/mg protein) was identified in all tumor specimens examined and three of the tumor cell lines. Three tumor cell lines, the human small cell carcinoma line SW2-10S, the Burkitt's lymphoma derived cell line Raji, and the human breast carcinoma cell line MCF-7, contained minimal GST activity. Although the small size of the tumor samples precluded isoenzyme analysis by substrate specificities, analysis of GST activity following sample separation by isoelectric focusing indicated that the predominant (comprising at least 70% of the 1-chloro-2,4-dinitrobenzene-conjugating activity) GST isoenzyme in each of these primary tumor (17 of 17) and tumor cell line (3 of 3) extracts was anionic (isoelectric point, 4.5-4.8). In three tumor samples, adenocarcinomas of the lung, colon, and stomach, analysis by isoelectric focusing identified minor but detectable (10-20% of total) cationic GST. The anionic form of GST has been purified to homogeneity from three primary human tumors: a malignant melanoma; a mesothelioma; and a breast carcinoma. GST from these tumors consists of two subunits each of Mr 25,200. On Western blot analysis, antibodies raised against the anionic GST purified from mesothelioma detect protein of Mr approximately 25,000 in extracts of both normal kidney and tumors containing anionic GST activity but not in extracts of human liver that did not contain detectable anionic activity. The amino acid compositions of these proteins were quite similar to that previously described for GST-pi and the amino-terminal amino acid sequences for these tumor-derived isoenzymes are identical to one another and to that previously described for GST-pi from human placenta. GST is a major enzymatic activity in many human malignancies, comprising as much as 3% of the cytosolic protein of some tumors. Anionic GST is the predominant form of glutathione transferase activity in many human tumors and human tumor cell lines. In selected tumor samples the predominant anionic GST isoenzyme has been identified as a member of the pi class of this enzyme family. In addition, at least 3 of 17 tumor samples contained lesser but detectable amounts of cationic GST, probably of the alpha class. By conjugating glutathione with electrophilic anticancer drugs, the substantial levels of GST in human tumors may have a role in the innate or acquired resistance of these neoplasms to anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275499

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Glutathione transferases in human nasal mucosa.

Authors:  A Aceto; C Di Ilio; S Angelucci; V Longo; P G Gervasi; G Federici
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil.

Authors:  S M Black; J D Beggs; J D Hayes; A Bartoszek; M Muramatsu; M Sakai; C R Wolf
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

3.  Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.

Authors:  X Y Hao; M Widersten; M Ridderström; U Hellman; B Mannervik
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

4.  Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

Authors:  J J König; E Kamst; A Hagemeijer; J C Romijn; J Horoszewicz; F H Schröder
Journal:  Urol Res       Date:  1989

5.  Overexpression of glutathione S-transferase pi messenger RNA and its relationship to gene amplification in head and neck squamous cell carcinoma.

Authors:  Z P Pavelic; X Wang; Y Li; L Gleich; J L Gluckman; P J Stambrook
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

6.  Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias.

Authors:  J Koberda; A Hellmann
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

7.  Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases.

Authors:  K Berhane; M Widersten; A Engström; J W Kozarich; B Mannervik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study.

Authors:  J D Collier; M K Bennett; A Hall; A R Cattan; R Lendrum; M F Bassendine
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 9.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

10.  Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.

Authors:  S Kuzmich; L A Vanderveer; E S Walsh; F P LaCreta; K D Tew
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.